Clinical Trials Directory

Trials / Completed

CompletedNCT00297024

Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study)

MRI Changes With Administered Oxygen and Carbon Dioxide in Patients With Brain Tumors Receiving Radiotherapy: A Pilot Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
14 (actual)
Sponsor
University Health Network, Toronto · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Brain tumours often have low oxygen levels, and that makes them more resistant to radiation therapy. If patients breathe the right mixture of oxygen during treatment, radiation may work better. In this study, patients with brain tumour will undergo a special MRI test while they breathe different mixtures of oxygen and carbon dioxide to find out whether oxygen levels improve in the tumor. Patients will also be asked to repeat this MRI test during the second week of radiation therapy, as well as 3 months, 6 months and 1 year after RT. The MRI test after RT will help us understand how the blood vessels in the normal brain are affected by radiation.

Conditions

Interventions

TypeNameDescription
PROCEDUREMRIPatients will be scanned while breathing in varying amounts of oxygen and carbon dioxide in varying amounts through a breathing device.

Timeline

Start date
2005-02-01
Primary completion
2013-05-01
Completion
2013-05-01
First posted
2006-02-27
Last updated
2014-01-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00297024. Inclusion in this directory is not an endorsement.

Radiotherapy - Cerebrovascular Reactivity (RT-CVR Study) (NCT00297024) · Clinical Trials Directory